MedCity News July 14, 2024
Walgreens’ financial performance is still rocky, but experts agree there is a good chance that CEO Tim Wentworth can lead the company to recovery. To make this happen, Walgreens will have to let go of its retail clinic dreams and focus more on making its core pharmacy business as strong as possible.
What is going on at Walgreens?
If you’re someone who has followed the healthcare stock market over the past few years, there’s a good chance you have asked that question. The Illinois-based pharmacy giant’s stock price has decreased by 80% in the past five years — currently trading at about $11 per share, compared to about $56 in July 2019.
The company’s trademark red cursive “W”...
Today's Sponsors
Today's Sponsor